A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States

PLoS Computational Biology

Volumn 11, Issue 4, 2015, Pages

  Gambhir, Manoj ^a,b,c   Clark, Thomas A ^b   Cauchemez, Simon ^d,e   Tartof, Sara Y ^f   Swerdlow, David L ^b   Ferguson, Neil M ^d  

^a MONASH UNIVERSITY   (Australia)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c Ihrc Inc   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e INSTITUT PASTEUR   (France)

^f KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; LARGE DATASET;

AGE GROUPS; DISEASE INCIDENCE; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL MODELING; FITTING MODEL; SURVEILLANCE DATA; SURVEILLANCE SYSTEMS; TIME-PERIODS; VACCINE EFFICACIES; WHOLE CELL;

VACCINES;

PERTUSSIS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION SENSITIVITY; PERTUSSIS; SCHOOL CHILD; SEROCONVERSION; TREATMENT DURATION; UNITED STATES; VACCINATION; ADULT; COMPUTER SIMULATION; FEMALE; HEALTH SURVEY; IMMUNIZATION; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; PROCEDURES; RISK ASSESSMENT; STATISTICAL MODEL; TREATMENT OUTCOME; UTILIZATION; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MODELS, STATISTICAL; POPULATION SURVEILLANCE; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; VACCINATION; VACCINE POTENCY; WHOOPING COUGH; YOUNG ADULT;

EID: 84929485991     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004138     Document Type: Article

References (53)

1. Winter K, Harriman K, Schechter R, Yamada E, Talarico J, Chavez G (2010) Notes from the Field: Pertussis—California, January—June 2010. MMWR 59.
2. CDC (2008) http://www.cdc.gov/pertussis/surv-reporting.html.
3. CDPH (2011) http://www.cdph.ca.gov/healthinfo/discond/pages/pertussis.aspx (California Department of Public Health, Pertussis reports).
4. CDC (2008) Chapter 10. Pertussis. In: Roush S, McIntyre L, Baldy L, editors. Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA
5. Simpson DM, Ezzati-Rice TM, Zell ER, (2001) Forty years and four surveys: how does our measuring measure up? Am J Prev Med 20: 6–14. 11331125
6. WHO (2010) http://www.who.int/immunization_monitoring/diseases/pertussis/en/index.html.
7. CDC (1991) Food and Drug Administration approval of use of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep 40: 881–882. 1749373
8. CDC (1992) Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 41: 1–5. 1480128
9. CDC (1996) Food and Drug Administration approval of an acellular pertussis vaccine for the initial four doses of the diphtheria, tetanus, and pertussis vaccination series. MMWR Morb Mortal Wkly Rep 45: 676–677. 8778580
10. CDC (1997) Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46: 1–25. 9427216
11. Cherry JD, (2003) The science and fiction of the "resurgence" of pertussis. Pediatrics 112: 405–406. 12897292
12. Cherry JD, Olin P, (1999) The science and fiction of pertussis vaccines. Pediatrics 104: 1381–1383. 10585991
13. World Health Organisation (2012) FluNet.
14. Lavine JS, King AA, Bjornstad ON, (2011) Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci U S A 108: 7259–7264. doi: 10.1073/pnas.1014394108 21422281
15. Rohani P, Zhong X, King AA, (2010) Contact network structure explains the changing epidemiology of pertussis. Science 330: 982–985. doi: 10.1126/science.1194134 21071671
16. Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P, (2010) Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Biol Sci 277: 3239–3245. doi: 10.1098/rspb.2010.0994 20534609
17. Raguckas SE, VandenBussche HL, Jacobs C, Klepser ME, (2007) Pertussis resurgence: diagnosis, treatment, prevention, and beyond. Pharmacotherapy 27: 41–52. 17192161
18. Wearing HJ, Rohani P, (2009) Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog 5: e1000647. doi: 10.1371/journal.ppat.1000647 19876392
19. Wood N, McIntyre P, (2008) Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 9: 201–211; quiz 211–202. doi: 10.1016/j.prrv.2008.05.010 18694712
20. Trottier H, Carabin H, Philippe P, (2006) [Measles, pertussis, rubella and mumps completeness of reporting. Literature review of estimates for industrialized countries]. Rev Epidemiol Sante Publique 54: 27–39. 16609635
21. Sutter RW, Cochi SL, (1992) Pertussis hospitalizations and mortality in the United States, 1985–1988. Evaluation of the completeness of national reporting. JAMA 267: 386–391. 1309387
22. Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, et al. (2012) Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 308: 2126–2132. doi: 10.1001/jama.2012.14939 23188029
23. Witt MA, Katz PH, Witt DJ, (2012) Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 54: 1730–1735. doi: 10.1093/cid/cis287 22423127
24. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, et al. (2013) Waning Immunity to Pertussis Following 5 Doses of DTaP. Pediatrics. doi: 10.1542/peds.2012-1928 23478868
25. Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. (2005) Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 353: 1555–1563. 16221778
26. Sheridan SL, Ware RS, Grimwood K, Lambert SB, (2012) Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308: 454–456. doi: 10.1001/jama.2012.6364 22851107
27. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, et al. (2010) Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis 14: e1072–1075. doi: 10.1016/j.ijid.2010.07.005 20951620
28. Fry NK, Duncan J, Wagner K, Tzivra O, Doshi N, Litt DJ, et al. (2009) Role of PCR in the diagnosis of pertussis infection in infants: 5 years' experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 58: 1023–1029. doi: 10.1099/jmm.0.009878-0 19528165
29. Kretzschmar M, Teunis PF, Pebody RG, (2010) Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 7: e1000291. doi: 10.1371/journal.pmed.1000291 20585374
30. Anderson R, May R, (1992) Infectious diseases of humans: dynamics and control: Oxford University Press. 768 p.
31. CDPH (2010) July 2010: California pertussis update.
32. Queenan AM, Cassiday PK, Evangelista A, (2013) Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 368: 583–584. doi: 10.1056/NEJMc1209369 23388024
33. Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, et al. (2015) Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage. Clin Infect Dis 60: 223–227. doi: 10.1093/cid/ciu788 25301209
34. Riolo MA, King AA, Rohani P, (2013) Can vaccine legacy explain the British pertussis resurgence? Vaccine 31: 5903–5908. doi: 10.1016/j.vaccine.2013.09.020 24139837
35. Choisy M, Rohani P, (2012) Changing spatial epidemiology of pertussis in continental USA. Proc Biol Sci 279: 4574–4581. doi: 10.1098/rspb.2012.1761 23015623
36. Rohani P, Drake JM, (2011) The decline and resurgence of pertussis in the US. Epidemics 3: 183–188. doi: 10.1016/j.epidem.2011.10.001 22094341
37. Bauch CT, (2005) Imitation dynamics predict vaccinating behaviour. Proc Biol Sci 272: 1669–1675. 16087421
38. Jackson DW, Rohani P, (2014) Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect 142: 672–684. doi: 10.1017/S0950268812003093 23324361
39. Quinn HE, Mahajan D, Hueston L, Campbell P, Menzies RI, Gilbert GL, et al. (2011) The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules. N S W Public Health Bull 22: 224–229. doi: 10.1071/NB11023 22243639
40. Spokes PJ, Quinn HE, McAnulty JM, (2010) Review of the 2008–2009 pertussis epidemic in NSW: notifications and hospitalisations. N S W Public Health Bull 21: 167–173. doi: 10.1071/NB10031 20883655
41. Menzies R, Wang H, McIntyre P, (2003) Has pertussis increased in NSW over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988–2002. N S W Public Health Bull 14: 71–76. 12806404
42. United Nations (2012) UN Data.
43. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74. doi: 10.1371/journal.pmed.0050074 18366252
44. Aguas R, Goncalves G, Gomes MG, (2006) Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis 6: 112–117. 16439331
45. CDC (2012) National Immunization Survey.
46. (2006) National, state, and urban area vaccination coverage among children aged 19–35 months—United States, 2005. MMWR Morb Mortal Wkly Rep 55: 988–993. 16971887
47. Vazquez-Fernandez del Pozo S, Hernandez-Barrera V, Carrasco-Garrido P, Alvarez-Martin E, Lopez-de Andres A, Gil de Miguel A, et al. (2007) Influenza vaccination coverage and related factors among Spanish children. J Infect 54: 483–489. 17046065
48. (2007) National, state, and local area vaccination coverage among children aged 19–35 months—United States, 2006. MMWR Morb Mortal Wkly Rep 56: 880–885. 17728693
49. (2008) National, state, and local area vaccination coverage among children aged 19–35 months—United States, 2007. MMWR Morb Mortal Wkly Rep 57: 961–966. 18772851
50. (2009) National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2008. MMWR Morb Mortal Wkly Rep 58: 997–1001. 19763075
51. (2010) National, state, and local area vaccination coverage among adolescents aged 13–17 years—United States, 2009. MMWR Morb Mortal Wkly Rep 59: 1018–1023. 20724968
52. Warfel JM, Zimmerman LI, Merkel TJ (2013) Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A.
53. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A, (2002) Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 64: 583–639.